Cargando…
Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity
BACKGROUND: The activity of cerebrospinal fluid (CSF) β-site APP cleaving enzyme (BACE) is a potential diagnostic biomarker for Alzheimer disease (AD). METHODS: A total of 340 non-Hispanic Caucasian participants from the Alzheimer’s Disease Neuroimaging Initiative cohort (ADNI) database were include...
Autores principales: | Hu, Hao, Li, Haiyan, Li, Jieqiong, Yu, Jintai, Tan, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948839/ https://www.ncbi.nlm.nih.gov/pubmed/29751835 http://dx.doi.org/10.1186/s12881-018-0603-z |
Ejemplares similares
-
Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012) -
BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System
por: Mattsson, Niklas, et al.
Publicado: (2012) -
The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer’s Disease
por: De Vos, Ann, et al.
Publicado: (2016) -
Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease
por: Liu, Ying, et al.
Publicado: (2014) -
Genome-wide association study identifies SIAH3 locus influencing the rate of ventricular enlargement in non-demented elders
por: Li, Xian, et al.
Publicado: (2019)